Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

GPR89A Activators

The chemical class known as GPR89A Activators encompasses a range of compounds that are understood to influence the signaling pathways related to the G protein-coupled receptor GPR89A. These activators are not linked by a common chemical structure or specific target activity but are instead characterized by their ability to modulate cellular processes that can indirectly lead to the activation of GPR89A. The primary methods by which these chemicals can exert their influence include the alteration of intracellular second messenger concentrations, such as cyclic AMP (cAMP) or calcium ions, and the modification of protein kinase activity, which are central to the regulatory mechanisms governing GPCR function. By increasing cAMP levels, for example, some of these activators can enhance the signaling of GPCRs that respond to elevated cAMP within the cell. Others can achieve similar outcomes by inhibiting the breakdown of cAMP, thereby sustaining its action in the cell.

Moreover, certain chemicals within this class can influence the GPR89A receptor by modulating protein interactions and the phosphorylation states of proteins involved in the signaling cascade. This includes the activation or inhibition of various G proteins and kinase enzymes such as protein kinase C (PKC) and G protein-coupled receptor kinases (GRKs). Some of these activators can also impact the cytoskeletal components of the cell, potentially influencing receptor function through changes in cellular architecture or dynamics. The GPR89A Activators do not share a singular mode of action but rather represent a diverse array of molecules that can alter the cellular signaling milieu in which GPR89A operates. These compounds can be instrumental in dissecting the complex pathways and networks that govern GPCR signaling, providing valuable insights into the intricate web of intracellular communication.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Activates protein kinase C, which could activate GPR89A by modulating GPCR signaling cascades.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Increases intracellular calcium levels, could activate GPR89A by influencing GPCR-related signaling linked to calcium signaling.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

A non-selective inhibitor of phosphodiesterases, preventing cAMP breakdown, could activate GPR89A by affecting GPCR signaling and cAMP levels.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$451.00
3
(1)

Inactivates Gi/o type G proteins, could activate GPR89A by altering signaling pathways.

PP1 Analog II, 1NM-PP1

221244-14-0sc-203214
sc-203214A
1 mg
5 mg
$106.00
$530.00
10
(1)

A potent and selective inhibitor of Gs alpha subunit, could activate GPR89A by affecting cAMP levels.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$105.00
$299.00
$474.00
15
(1)

A broad-spectrum PKC inhibitor, could activate GPR89A by modulating various GPCR signaling cascades.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

A ROCK inhibitor, could activate GPR89A by impacting cytoskeletal arrangement and cell contractility if it's coupled to such cellular processes.